In India, the Russian-developed Corona Vaccine Sputnik V has been approved for emergency use. This is the third vaccine for the coronavirus to be approved after Kovshield (Serum Institute of India) and Kovaxin (Bharat Biotech).
The Sputnik V vaccine, developed by Moscow's Gamale National Research Institute of Epidemiology and Microbiology, uses two different viruses that cause the common cold (adenovirus) in humans. Adenovirus becomes weak so it cannot replicate in humans and cannot cause disease.
Let me tell you that this vaccine is also modified. For this reason, the vaccine provides a code for making the coronavirus spike protein. The purpose of this process is to ensure that when the actual virus tries to infect the body, it can mount an immune response in the form of antibodies.
Sputnik uses a different vector for each of the two shots during vaccination. According to this Russian Direct Investment Fund (RDIF), the same methods are used for both shots. It provides immunity with a longer duration than other vaccines. A difference of 21 days is required for both shots.
Sputnik V (liquid) is stored at a temperature of minus 18 ° C. However, its dried form can be stored at 2–8 ° C. This does not require investing in cold-chain infrastructure. According to the RDIF, Sputnik V has been approved for the use of more than 150 crore people in 55 countries. The vaccine is proposed to be priced below $ 10 per shot. Although its price in India has not been decided.
Dr. Reddy's labs based in Hyderabad sought government approval for the vaccine in India. RDIF partnered with Dr. Reddy's in September 2020 to conduct clinical trials in the country. On Monday, the Subject Expert Committee (SEC) of the Drugs Controller General of India took the Sputnik V application for Emergency Use Authority and moved on. DCGI previously sought additional data from the drug manufacturer.
Five other Indian companies have partnered with RDIF for Sputnik V. These include Gland Pharma, Hetero Biopharma, Virchow Biotech, Panacea Biotech, and Stellis Biopharma, Bangalore-based Strides Pharma Science's bioceramic. It is expected from their partnerships that India's capacity to manufacture this vaccine will exceed 60 million.
There is considerable excitement among film enthusiasts regarding South Indian superstar Mahesh B
FTX, one of the world's largest crypto exchanges, applied for bankruptcy on Friday. People did no
India's Foreign Minister S Jaishankar has put a condition on Monday for starting talks with Pakis
UP is ready: Preparations to promote Nipun Bharat Mission, a program organized on July 21 in Lucknow
Under the New Education Policy, 2020, the Government of Uttar Pradesh is going to take forward th
War has erupted in the Middle East following a US-Israeli attack on Iran. Iran has taken control
Another action has been taken by the NIA investigating the Antilia case involving a suspected car
A horrific road accident took place late Friday night in Buldhana district of Maharashtra. 26 pas
Former CM Arvind Kejriwal and CM Atishi held a press conference regarding the bad roads of the ca
After Imran Khan, now PTI leader Fawad Chaudhary also made fun of the judiciary, know what he said
Imran Khan's party PTI is constantly attacking the government. While pointing fingers at the gove
Treatment of corona infected in rural areas with the help of hawk doctors
Gurugram / Pataudi. Treatment of uncontrolled corona infects in the rural areas of the district i
